Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: Yes

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 12, 2006, Pages 2527-2529

  Cosmi, Benilde ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; D DIMER; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CANCER; CHRONIC DISEASE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK PATIENT; HUMAN; INFLAMMATORY DISEASE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; THROMBOEMBOLISM; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BIOLOGICAL MARKERS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK FACTORS; VENOUS THROMBOSIS; VITAMIN K;

EID: 33750981871     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02247.x     Document Type: Article

References (10)

1. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest 2004; 126: 401S-28S.
2. Kevorkian JP, Halimi C, Segrestaa JM, Drouet L, Soria C. Monitoring of patients with deep-vein thrombosis during and after anticoagulation with D-dimer. Lancet 1998; 351: 571-2.
3. Fattorini A, Crippa L, ViganòD'Angelo S, Pattacini E, D'Angelo A. Risk of deep vein thrombosis recurrence: High negative predictive value of D-dimer performed during oral anticoagulation. Thromb Haemost 2002; 88: 162-3.
4. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolic recurrence: High negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002; 87: 7-12.
5. Kuruvilla J, Wells P, Morrow B, MacKinnon K, Keeney M, Kovacs MJ. Prospective assessment of the natural history of positive D-dimer results in persons with acute venous thromboembolism (DVT or PE). Thromb Haemost 2003; 89: 284-7.
6. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S. Poor anticoagulation quality in the first three months after unprovoked venous thromboembolism is a risk factor for long term recurrence. J Thromb Haemost 2005; 3: 955-61.
7. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 2003; 290: 1071-4.
8. Palareti G, Legnani C, Cosmi B, ValdrèL. Lunghi B, Bernardi F, Coccheri S. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-8.
9. Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost 2005; 94: 969-74.
10. Palareti G, Tosetto A, Cosmi B, Legnani C, Brusi C, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Iorio A, Tripodi A. The D-dimer test to establish the duration of anticoagulation after a first unprovoked episode of venous thromboembolism l. (VTE); the prospective randomized "Prolong" study. J Thromb Haemost 2005; 3: H02.